Dovetail Genomics LLC, a leading player in the genomics industry, is headquartered in the United States and operates across various regions globally. Founded in 2013, the company has made significant strides in advancing genomic technologies, particularly in the areas of genome assembly and structural variant detection. Dovetail Genomics is renowned for its innovative products, including the Dovetail Hi-C technology, which offers unparalleled insights into genome architecture and organisation. This unique approach sets the company apart, enabling researchers to achieve high-resolution genomic mapping with exceptional accuracy. With a strong market position, Dovetail Genomics has garnered recognition for its contributions to genomics, supporting a diverse range of applications from agriculture to human health. The company continues to push the boundaries of genomic research, solidifying its reputation as a trusted partner in the scientific community.
How does Dovetail Genomics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dovetail Genomics LLC's score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dovetail Genomics LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Dovetail Genomics may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change. However, without specific commitments or emissions data, it is unclear how Dovetail Genomics aligns with these industry standards. As the company progresses, it may consider implementing strategies to measure and reduce its carbon emissions in line with best practices in environmental stewardship.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dovetail Genomics LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

